|
Henry, this diatribe regarding PI therapy is almost unbearable to me. You know very well the consequence of ineffective, improperly, and inadequately HIV disease vs the possible effects of PI therapy, which are rather minimal for Viracept as compared, eg., to Crixivan. Perhaps you, and others, can reread posts 4658, 4860, 4862. Do any of the LGND drugs "cure" any HIV/AIDS disease? If not, why proceed with drug development and potential marketing? IMO, you have to offer the patient the best currently available treatment until there is a curative treatment and/or preventative modality available, which is the direction AGPH is trying to go. For some reason, I still get the impression that you are trying to "knock-down" AGPH, while continuing to promote LGND. Perhaps I'm just reading you wrong, since you are obviously not an AGPH stockholder but are obviously an excellent scientist. |
